FY 2018 total revenue £502k increased 111% (FY 2017 : £238k);
FY 2018 revenue from continued operations £274k increased 294% (FY 2017 : £93k) following Labskin test kit sales move to full skin-care product test services;
FY 2018 EBITDA losses reduced by 12% to (£1.25m) (FY 2017: (£1.40m))
Launch of Labskin human skin clone tests for Medical Device and Clinical Research trials. Combined with human volunteers doubles number of skin tests possible saving time and money.
Fionán Murray has joined Integumen as Group Sales Director, and as a Director of the Company with a focus on extending digital services on top of existing Labskin physical services to rapidly grow the Labskin AI footprint.
Gerry Brandon, the Company’s CEO, will be presenting at an investor evening hosted by Turner Pope Investments (TPI) Ltd, on Monday 13th May 2019
Labskin STOER study demonstrates 54% increase in skin hydration in 24 hours Promotion of new skin cells leaving fresher looking skin Launch of New Animal-Free Labskin Dandruff Test Integumen today announces the completion of development and launch of a new dandruff...
Integumen announces acquisition of RinoCloud Ltd, an integrated scientific data management services company for £3m. Placement for £2.5m and £1m debt reduction
Integumen plc (AIM: SKIN) announces agreement with Cellulac Limited to acquire hi-tech laboratory test equipment, to be installed into the enlarged Labskin UK laboratories in York.
Labskin CBD tests show greater than 99% reduction in bacterial growth on human skinIntegumen plc (AIM: SKIN) is pleased to announce a greater than 99% reduction of bacterial growth in preliminary results of four formulations, all of which include Cannabinoid (CBD)...
H2 480% increase in Labskin revenues. Positive results of major restructuring and accelerated growth in product sales and contract test services
Divestment of TSPro GmbH to remove c€1.34m (£1.19m) of short and long term liabilities from Integumen Today the Company announces the divestment (“Disposal”) of TSpro GmbH (“TSPro”), a wholly-owned subsidiary of Integumen plc. The Company has entered into a...